Scientists found that, in hepatocellular carcinoma (HCC) patients and animal models, advanced glycation end-products promoted changes in collagen architecture and enhanced ECM viscoelasticity, with greater viscous dissipation and faster stress relaxation, but not changes in stiffness.
[Nature]